ISRCTN47214063已完成不适用
Simvastatin (20 mg) vs ezetimibe (10 mg) plus simvastatin (20 mg) in subjects with hypercholesterolaemia and coronary heart disease (CHD)
Schering-Plough UK Ltd0 个研究点目标入组 0 人开始时间: 2004年8月13日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Male or female subjects aged 18-75 years with screening low-density lipoprotein cholesterol (LDL-C) between 3.3 and 4.9 mmol/l
排除标准
- •Not provided at time of registration
研究者
相似试验
进行中（未招募）
不适用
The effect of Ezetimibe 10 mg, Simvastatin 20 mg and the Combination of Simvastatin 20 mg plus 10 mg Ezetimibe on LDL-Subfractions in patients with Type 2 Diabetes (Die Wirkung einer Monotherapie mit Ezetimib 10 mg vs. Monotherapie mit Simvastatin 20 mg vs. Kombinationsbehandlung mit Ezetimib 10 mg und Simvastatin 20 mg auf die LDL-Subfraktionen bei Patienten mit Typ II Diabetes)well controlled type II diabetes mellitus (HbA1c < 8.0 %) with a preponderance of atherogenic small, dense LDL (LDL-5 and LDL-6 > 25 mg/dL)MedDRA version: 8.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2006-005906-30-DEniversitätsklinikum Freiburg, Abteilung klinische Chemie60
已完成
3 期
A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)Coronary DiseaseNCT00551447Organon and Co616
已完成
4 期
Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)HypercholesterolaemiaAtherosclerosisNCT00653835Organon and Co153
已完成
4 期
The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin StudyMetabolic SyndromeNCT00817843dr.Frank L.J. Visseren100
已完成
3 期
Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)Hyperlipoproteinemia Type IIAtherosclerosisHypercholesterolemiaNCT00552097Organon and Co720